导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 24.67% | 159/1050 |
| 近一周 | -3.12% | 808/1104 |
| 近一月 | -7.71% | 892/1102 |
| 近一季 | -12.98% | 782/1092 |
| 近半年 | 23.81% | 107/1070 |
| 近一年 | 24.02% | 194/1018 |
| 近两年 | 142.07% | 111/926 |
| 近三年 | 67.46% | 163/834 |
| 成立以来 | 203.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.02% 718/1070 |
85.51% 82/1101 |
- - |
- - |
| 2025 | 42.50% 288/1065 |
10.46% 143/1014 |
1.57% 545/1038 |
40.73% 181/1050 |
-9.75% 878/1065 |
| 2024 | 2.25% 520/1011 |
-14.27% 895/960 |
-0.75% 360/983 |
15.76% 186/991 |
3.81% 166/1011 |
| 2023 | -5.59% 216/952 |
28.86% 15/880 |
-7.20% 650/895 |
-14.92% 772/915 |
-7.21% 696/952 |
| 2022 | -20.66% 351/867 |
-24.26% 710/773 |
-6.37% 766/806 |
-3.71% 43/845 |
16.19% 32/867 |
| 2021 | 29.74% 72/740 |
-6.69% 407/580 |
32.64% 44/659 |
-4.68% 339/704 |
9.98% 85/740 |
| 2020 | 49.57% 238/554 |
4.93% 77/419 |
21.60% 258/466 |
4.10% 374/517 |
12.61% 266/554 |
| 2019 | 55.79% 104/410 |
39.14% 69/1146 |
-9.91% 1052/1228 |
14.89% 39/390 |
8.18% 231/410 |
| 2018 | - - |
- - |
- - |
2.98% 92/1000 |
-5.48% 66/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中欧电子信息产业沪港深股票C VS. 东吴新产业精选股票A(580008) |